Mucopolysaccharidosis II: MPS II, also called Hunter syndrome, affects juveniles and includes a mild and a severe form. Signs of the severe form are ... more about Mucopolysaccharidosis II.
Mucopolysaccharidosis II: Disorder of mucopolysaccharide metabolism in juveniles. More detailed information about the symptoms, causes, and treatments of Mucopolysaccharidosis II is available below.
See full list of 12 symptoms of Mucopolysaccharidosis II
Read more about complications of Mucopolysaccharidosis II.
Research the causes of these diseases that are similar to, or related to, Mucopolysaccharidosis II:
Read more about treatments for Mucopolysaccharidosis II
Medical news articles related to Mucopolysaccharidosis II include:
Source: HealthDay News
Medical research articles related to Mucopolysaccharidosis II include:
Click here to find more evidence-based articles on the TRIP Database
"I authorize the release of any medical or other information necessary to process this claim." Do you recognize these words? You should, if...
Whenever you go to a hospital or clinic for a major procedure or diagnostic test, one of the many forms you are given to sign is an "informed...
Germs are a fact of life and catching an infectious disease like a cold may seem inevitable. But there are simple ways to protect yourself against...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...
Prognosis for Mucopolysaccharidosis II: Usually death by age 15 for severe form; can have normal lifespan for mild form.
More about prognosis of Mucopolysaccharidosis II
Visit our research pages for current research about Mucopolysaccharidosis II treatments.
The US based website ClinicalTrials.gov lists information on both federally and privately supported clinical trials using human volunteers.
Some of the clinical trials listed on ClinicalTrials.gov for Mucopolysaccharidosis II include:
Read more about Clinical Trials for Mucopolysaccharidosis II
Types of Mucopolysaccharidosis II
Read more about Types of Mucopolysaccharidosis II
Related forums and medical stories:
Read about other experiences, ask a question about Mucopolysaccharidosis II, or answer someone else's question, on our message boards:
MPS II, also called Hunter syndrome, affects juveniles and includes a mild and a severe form. Signs of the severe form are joint stiffness, mental deterioration, dwarfing, and progressive deafness. Death usually occurs by age 15. Symptoms of the mild form include short stature, limitation of motion, and features such as an enlarged forehead, lips, and tongue and misaligned teeth. (Source: excerpt from NINDS Mucopolysaccharidoses Information Page: NINDS)
An inborn mucopolysaccharide metabolism disorder with iduronate-2-sulfatase deficiency. Clinical characteristics are similar to those in MPS I, except for the absence of corneal clouding and slower progression of the course of disease and central nervous system deterioration. Retinal degeneration may occur, but the cornea usually remains clear. Appearance is normal at birth with excessive growth taking place during first two years of life. Two types are recognized: A severe form (MPS IIA) which is characterized mainly by mental retardation and progressive physical deterioration and early death, and a mild form (MPS IIB) in which patients may survive into adulthood. MPS IIA usually occurs between 2 and 4 years of age with progressive deterioration, chronic diarrhea, recurrent ear infections, hearing impairment, communicating hydrocephalus with increased intracranial pressure, and death at about 10 and 15 years. Obstructive airway disease, cardiac valvular dysfunction, myocardial thickening, pulmonary hypertension, coronary disease, and myocardial infarction may be superimposed. MPS IIB is milder with preservation of intelligence. The symptoms usually include hearing impairment, carpal tunnel syndrome, joint stiffness, discrete corneal opacities, and papilledema. Death may occur in early adulthood, usually from airway obstruction or cardiac failure. - (Source - Diseases Database)
Mucopolysaccharidosis II is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Mucopolysaccharidosis II, or a subtype of Mucopolysaccharidosis II,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Mucopolysaccharidosis II as a "rare disease".
Source - Orphanet
» Next page: What is Mucopolysaccharidosis II?
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
